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Abstract
Background: The success of chlamydia screening programmes relies on their ability to effectively target those with
greatest need. Young people from disadvantaged backgrounds may be at greater need for chlamydia screening,
but existing evidence on the variation of prevalence with social position is inconclusive. We carried out a systematic
review to examine variation in chlamydia prevalence in populations and possible sources of this variation.
Methods: Studies were eligible if they reported chlamydia prevalence derived from population-based samples that
included young people aged 15–24 years from Europe, North America or Australia. Systematic searches of the
following databases were undertaken from their inception to November 2014: MEDLINE, Embase, Web of Science
and PsychINFO. There were no restrictions by language or publication date. Independent screening for eligibility
and data extraction were carried out by two reviewers. Where possible, data were pooled in a meta-analysis using a
random effects model. Heterogeneity was further investigated using meta-regression techniques.
Results: Of 1248 unique titles and abstracts and 263 potentially relevant full texts, 29 studies were eligible for
inclusion. There was relatively strong evidence that disadvantaged young people had an increased risk of having a
chlamydia infection across multiple measures of disadvantage, including lower educational attainment (OR 1.94,
95 % CI: 1.52 to 2.47), lower occupational class (OR 1.49, 95 % CI: 1.07 to 2.08) and residence in deprived areas
(OR 1.76, 95 % CI: 1.15 to 2.71) with an overall OR of 1.66 (95 % CI: 1.37 to 2.02). Socioeconomic disadvantage was
associated with chlamydia infection in both men and women. There was weaker evidence that prevalence
estimates also varied by gender and age.
Conclusions: This review provides evidence of a consistent association between socioeconomic disadvantage and
higher risk of Chlamydia infection. This association may reflect a number of factors including social variation in
engagement with Chlamydia control programmes. Chlamydia screening could therefore reduce or increase health
inequalities, depending on service provision and uptake by different socioeconomic groups.
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Background
The success of chlamydia screening programmes is likely
to depend on their ability to effectively reach individuals
at greater risk of chlamydia [1]. In England, recent policy
guidance for the National Chlamydia Screening Pro-
grammes seeks both to increase the proportion of
screening participants who test positive and to ensure
high levels of coverage [2]. Information on the distribu-
tion of risk of chlamydia infections in populations can
be used to inform screening strategy and the impact of
particular strategies can be monitored directly or ex-
plored through modeling [3–8]. Screening programmes
that fail to reach those at greatest risk may exacerbate
existing health inequalities [9].
Socioeconomic position has been considered as a poten-
tial source of variation in chlamydia prevalence [4, 5, 10].
Although there is substantial evidence of socioeconomic
inequalities in other aspects of sexual health [11, 12], evi-
dence is less clear as to whether this is true for chlamydia
infections. A previous qualitative systematic review found
inconclusive evidence that chlamydia infections vary by
socioeconomic position [10].
Surveillance data on positivity among chlamydia screen-
ing service users suggests that risk of infection is higher
among women than men and is higher among men aged
19 to 24 years than younger men [8, 13, 14]. However, rou-
tine health service data are unlikely to yield valid estimates
of true prevalence in the general population, because those
who use health services may differ systematically from
those who do not, and data on non-users are usually un-
available [15–18]. Population-based studies based on repre-
sentative samples are the observational method with the
greatest level of external validity for estimating prevalence
and the distribution of risk of infection in a population.
However, population-based studies provide wide variations
in prevalence estimates, sometimes even in the same popu-
lation, and are often underpowered to identify any differ-
ences by population sub-group (e.g., as defined by gender
or age [15–17]). Various types of participation bias, result-
ing from differential participation in studies of individuals
with different risks of infection, may lead to variations in
population-based prevalence estimates. This question has
not previously been the subject of systematic study.
This review aims to identify population-based studies
of chlamydia infection in women and men aged 15–24
years in higher income countries of Europe, North America
and Australia. These settings were chosen as they all have
Chlamydia control programmes focused on this age group
involving population testing and antibiotic treatment.
We further aimed to examine evidence for variation in
risk of infection by factors that may have implications
for design of control programmes such as gender, age
and socioeconomic position and variation by study
characteristics that may be indicators of potential for
selection bias such as response rate, and sexual health
or general health study focus.
Methods
Search strategy
PRISMA guidelines were followed throughout this sys-
tematic review [19], which was conducted using an a
priori protocol. Search strategies suitable for each bib-
liographic database were developed using a combination
of special index search terms (including medical subject
headings (MeSH)), text word searches of titles and ab-
stracts, and synonyms for genital chlamydia infection,
population-based studies and prevalence. Search strategies
were reviewed by a librarian with bibliographic database
expertise and refined accordingly. Details on the searches
are provided in an additional file (Additional file 1). We
carried out searches of MEDLINE (1950 to the present),
Embase (1974 to the present), Web of Science (1900 to
the present) and PsychINFO (1987 to the present) from
their inception to 14th November 2014. An additional
hand search of references cited by relevant papers and sys-
tematic reviews was carried out by one reviewer (JC). All
publications identified by the searches were imported into
the Endnote X7.1 reference management software [20].
Study selection
The eligibility criteria for this review were studies that:
(i) were population-based (defined as universal or ran-
dom sampling of individuals from a sampling frame that
closely matched the general population in a defined geo-
graphical area); (ii) included young people aged 15–24
years; (iii) were undertaken in Europe, North America
or Australia; (iv) provided original data on prevalent
chlamydia infection detected by laboratory diagnostic
test. There were no restrictions by language or publica-
tion date. Studies based on non fee-paying public sector
schools were also eligible for inclusion.
Two reviewers (JC and HB-F) independently screened
titles and abstracts of 1248 candidate studies and the full
texts of 263 considered to be potentially eligible for in-
clusion. One author (JC) carried out quality appraisal
using the Critical Appraisal Skills Programme (CASP)
checklist for appraising cohort studies [21], which was
adapted to serve the aims and research question for this
study. Due to the observational nature of the primary
studies, quality appraisal was primarily undertaken to
highlight potential sources of bias. No studies were ex-
cluded because of risk of bias.
Data extraction
Information was extracted by one reviewer (JC) on: type
of study, year of data collection, specimen type, diagnostic
test, age group and gender of participants, response rate,
number of individuals tested, and results. This was double
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checked by another (HB-F). Data were extracted by gen-
der where this was reported in the original study. If stud-
ies did not report this, data were extracted for men and
women combined. For socioeconomic measures, data on
the most and least socially disadvantaged subgroup were
extracted, taking the least disadvantaged as the reference
group. Socioeconomic measures were grouped as follows:
i) measures of young person’s educational opportunities
or achievement (ie number of years of schooling, or
academic v vocational high school); ii) measures of
young person’s occupation or employment (unemployed v
employed in USA and Croatia, measure of occupational
class in UK); iii) neighbourhood measure of deprivation
(the UK Government’s Index of Multiple Deprivation);
and iv) measures of parental income, education and/or
employment. Additional information on socioeconomic
measures used in included studies and comparator groups
for these is provided in (Additional file 2). Unreported
sample sizes, response rates, standard errors and odds
ratios were calculated using data reported in retrieved
papers. The characteristics of the studies were presented
in tables and grouped according to geographical area.
Adjusted Odds Ratios (ORs) were used where available,
otherwise unadjusted ORs were used.
Statistical analyses
Heterogeneity, or the percentage of variation between
studies that cannot be attributed to within-study vari-
ation, was estimated using the Q statistic and the I2 stat-
istic [22]. Evidence of heterogeneity was categorised as
weak, moderate or strong, based on an I2 greater than
20 %, 50 % and 80 %, respectively. Random effects
models were used to generate summary statistics where
heterogeneity was weak or moderate. Heterogeneity in
prevalence estimates was investigated by stratifying
meta-analyses by gender and type of socioeconomic pos-
ition measure and by meta-regression. Stratifying by type
of diagnostic test was also planned, but too few studies
were identified that involved low sensitivity diagnostic
tests for this to be possible. Heterogeneity in estimates
of associations between prevalence and socioeconomic
position was investigated by stratifying meta-analyses by
type of socioeconomic position measure and gender. For
meta-regression analysis, dummy study-level explanatory
variables were created for gender, age (binary measure of
age of the majority of participants: under versus over
20 years old), region (Europe versus other regions), re-
sponse rate (continuous variable), topic of study (binary
measure: general health or a sexual health study), sample
size (continuous variable) and the timing of data collec-
tion. The latter involved a binary variable of before or
after 2006, which was used as an approximate measure
of whether the study was carried out before or after
screening policies for chlamydia were widely introduced
[23, 24]. The topic of the study was potentially import-
ant as a sexual health focused study may have a different
response pattern to a general health study. It was not
possible to include socioeconomic position in the meta-
regression analyses due to missing or incompatible
dummy variable data. The proportion of the sample with
positive results was used as the dependent variable and
study-level factors as the independent variables. There
was insufficient power to test for interactions between
factors such as gender and age.
Results
Thirty-six papers relating to twenty-nine population-based
studies of chlamydia prevalence were identified (Fig. 1).
Of these, 14 studies examined variation in prevalence
by socioeconomic position. Reasons for study exclusions
of full texts included: lack of new positivity results (n =
47); not population-based (57); geographical ineligibility
(95); selective sampling of high risk geographical areas
(7), and; modelling studies or reviews (21).
The main characteristics of the included studies are
described in Additional file 2. All studies were single
country. Three (10 %) studies were carried out in the
UK, nineteen (65 %) were from elsewhere in Europe
(Belgium, Croatia, Denmark, Estonia, France, Germany,
the Netherlands, Norway, Spain, Slovenia, Sweden), six
(21 %) were from the United States of America (USA)
and one was from Australia. Nine (31 %) of the studies
were household surveys, ten (34 %) were postal screen-
ing surveys or trials of postal screening, four (14 %) were
school-based surveys, and six (21 %) used other methods
(four combined postal invitation and clinic-based data
collection, one used mixed sampling methods and one
was a birth cohort study). The majority of studies (24,
83 %) focused on sexual health, whereas five (17 %) stud-
ies examined health more broadly.
Twelve out of 27 (40 %) of the studies were assessed
to be ‘high risk’ that the results were due to bias or
chance, 16 (55 %) as ‘medium risk’ and only one study
was assessed to be ‘low risk’. Risk of selection bias was a
particularly common problem, with 24 studies (83 %)
assessed to be at high or medium risk of having selection
bias. Additional file 3 provides the risk of bias and rele-
vance assessment for the included studies.
Association with educational measures
Ten studies examined the relationship between educa-
tional opportunity or attainment of the respondent and
their odds of having chlamydia infection [4, 25–33]. In
most cases, educational attainment was measured by
number of years in education or high school graduation.
In two studies, general, academic or art schools were
compared with technical and vocational schools [27, 33].
Combined results showed evidence of an association
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between lower educational opportunities/attainment and
increased risk of chlamydia infection (Combined OR
1.94, 95 % CI: 1.52 to 2.47, I2 = 28.7 %, p = 0.149)
(Fig. 2, panel a). Subgroup analysis by gender was carried
out to examine whether associations varied between
men and women. Combined effect estimates were simi-
lar for observations based on men, women and for stud-
ies reporting results for both sexes combined, although
evidence of heterogeneity varied (Combined OR 1.89,
95 % CI: 1.24 to 2.89, I2 = 42.1 %, p = 0.141 in women;
Combined OR 1.75, 95 % CI: 1.18 to 2.58, I2 = 0.0 %,
p = 0.692 in men; Combined OR 2.22, 95 % CI: 1.28 to
3.87, I2 = 59.1 %, p = 0.062 in both sexes).
Three studies examined chlamydia infections by the
occupation or employment of the respondent
[4, 34, 35]. Results for an association with chlamydia in-
fection were equivocal for occupational class in men or
women in Britain [34] but stronger for measures of
unemployment in household surveys in Croatia and the
USA [4, 35]. Combining estimates gave evidence of an
association between lower occupational class or un-
employment and chlamydia infection (Combined OR 1.49,
95 % CI: 1.07 to 2.08, I2 = 29.7 %, p = 0.223) (Fig. 2, panel
b). There were too few studies to stratify results by gender.
Three studies, all from the UK, examined associations
between area deprivation and chlamydia infections
[32, 36, 37]. Across both genders, there was evidence
of an association between increased neighbourhood
deprivation and chlamydia infection (Combined OR 1.76,
95 % CI: 1.15 to 2.71), although there was substantial
evidence of heterogeneity (I2 = 73.6 %, p = 0.004)
(Fig. 2, panel c). There were too few studies to stratify
results by gender.
Four studies examined chlamydia prevalence using mea-
sures relating to the respondent’s parents. These included
parental income, occupation or education [32, 33, 38, 39].
Fig. 1 Flow diagram of records identified, included and excluded
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There was considerable evidence of heterogeneity
(I2 = 76.1 %, p = 0.002) and no evidence of an association
after pooling estimates (Combined OR 0.97, 95 % CI: 0.43
to 2.21). Two studies from the UK and the USA provided
evidence of an association between parental socioeco-
nomic position and chlamydia infection in both sexes, but
there were equivocal results among women in Germany
[38]. In rural Norway, lower maternal education was asso-
ciated with decreased odds of having chlamydia in women
but not in men [33].
Prevalence and other sources of heterogeneity
Overall, there was strong evidence of heterogeneity in
prevalence estimates for men (p < 0.001, I2 = 92.2 %) and
for women (p < 0.01; I2 = 91.9 %). Evidence of heterogeneity
among European studies remained strong after stratifying
by gender, age group and region (p < 0.001, I2 = 82.4 % in
women aged under 20 years; I2 = 83.3 %, p < 0.001 in
women aged over 20 years; I2 = 85.5 %, p < 0.001 in men
aged under 20 years and I2 = 80.5 %, p < 0.001 in men aged
over 20 years) and by response rate and overall risk of bias
Fig. 2 Odds ratio for chlamydia infection by socioeconomic position measures
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assessment. There were too few observations among sub-
groups outside Europe to synthesise results.
Across studies of prevalence within and outside Europe,
estimates of prevalence ranged between 0.6 % (95 % CI 0,
3.5) and 10.7 % in young women and between 0 % and
6.7 % (95 % CI 5.0, 8.8) in men (Table 1). Even within indi-
vidual countries, age- and gender-specific prevalence esti-
mates varied between studies by a factor of 2 or 3
[26, 28, 30–32, 36, 37, 39–45].
Chlamydia prevalence estimates were higher in women
than men in most studies [25, 26, 28, 32–34, 36, 37, 39,
40, 46, 47]. However the confidence intervals between
the sexes almost always overlapped, with the exception
of under 20 year olds in four studies from Britain,
Germany, the Netherlands and USA (NHANES 1999–
2002) [28, 37–39].
Nine studies enabled comparison of prevalence by age
[26, 29, 31, 36, 37, 39, 43, 45, 48]. Some of these studies
suggested that prevalence estimates in young men may
vary considerably by age, remaining low in those aged
under 20 years before peaking at 20–24 years. Preva-
lence was greater in men aged over 20 years in five stud-
ies [26, 36, 37, 45, 48], similar in one [28] and greater in
men aged 18 to 21 years in another [29]. There appeared
to be less of a difference for women. In women, preva-
lence peaked in those aged under 20 years in three stud-
ies [28, 29, 37], was similar in another two [30, 36] and
peaked in women aged over 20 years in one study [26].
The confidence intervals between age groups overlapped
in most studies.
Potential sources of heterogeneity in prevalence were
further explored using meta-regression analysis. Gender
and age were were associated with prevalence in both
univariable and mutually adjusted models (adjusted risk
difference (RD) 0.011, 95 % CI: 0.001 to 0.021) for fe-
male sex and RD 0.011, 95 % CI: 0.000 to 0.022 for age
over 20 years) (Table 1). There was no evidence that re-
gion, date or topic of study, response rate, or number of
young people tested were associated with prevalence es-
timates. The adjusted R2 for the multivariable regression
model was 21.5 % and the residual I2 was 79.2 %, indicating




Our systematic review found strong evidence of an asso-
ciation between chlamydia infection and socioeconomic
position in both men and women (Combined OR: 1.66,
95 % CI: 1.37 to 2.02). Pooled results were equivalent
to a doubled risk of chlamydia infection for those with
lower educational attainment (Combined OR: 1.94,
95 % CI: 1.52 to 2.47). Risk of infection was also greater
in those with lower occupational class or unemployment
and greater area deprivation. No association was found be-
tween chlamydia infection and parental or household
measures of income, occupation or education.
There was considerable variability in the prevalence of
chlamydia between population-based prevalence studies.
This variation presumably in part reflects differences in









Unadjusted model Mutually adjusted
Risk difference
(95 % confidence interval)
p value
Risk difference
(95 % confidence interval)
p value
Gender Men 24 (17) 1 1
Women 28 (20) 0.010 (0.000, 0.020) p = 0.043 0.011 (0.001, 0.021) p = 0.031
Age Under 20 24 (12) 1 1
Over 20 28 (15) 0.013 (0.004, 0.023) p = 0.008 0.011 (0.000, 0.022) p = 0.048
Region Europe 44 (17) 1 1
Outside Europe 8 (4) 0.004 (−0.010, 0.018) p = 0.577 0.012 (−0.005, 0.030) p = 0.160
Response rate
(per 10 % increase)
52 (21) 0.000 (−0.003, 0.003) p = 0.981 0.000 (−0.004, 0.004) p = 0.998
Study topic General health 9 (4) 1 1
Sexual health 43 (17) 0.009 (−0.004, 0.021) p = 0.165 0.010 (−0.006, 0.027) p = 0.208
Date Before 2006 37 (17) 1 1
After 2006 15 (5) −0.001 (−0.013, 0.011) p = 0.830 0.003 (−0.008, 0.015) p = 0.558
Number tested
(per 1000 increase in sample)
52 (21) 0.001 (−0.003, 0.004) p = 0.775 0.000 (−0.004, 0.004) p = 0.985
aThe number of studies adds to more than 21 for gender, age and date of study because some studies reported multiple prevalence estimates for these variables
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populations and underlying prevalence between coun-
tries. However, there were also variations in estimated
prevalence within populations. Evidence of heterogeneity
remained strong, even after stratifying meta-analyses by
gender, age and region. Prevalence estimates in young
men were lower in those aged under 20 years than 20 to
24 year olds in some studies but tended to be similar in
women aged under and over 20 years.
Meta-regression suggested that age and gender may
contribute to the heterogeneity of prevalence estimates.
Interpreted on the prevalence scale, multivariable meta-
regression suggested that prevalence is on average 1.1 %
(95 % CI 0.1 to 2.1 %) higher in women than men and
1.1 % (95 % CI 0.0 to 2.2 %) higher in 20 to 24 year olds
compared to under 20 year olds. However, the variables
included in the regression model explained only a mod-
est amount of the between-observation variance (ad-
justed R2 = 21.5 %) and strong evidence of residual
variation due to heterogeneity remained (I2 = 79.2 %).
Other potential sources of heterogeneity include the
residual influence of study characteristics such as non-
response bias, sampling bias and differences in true
prevalence between populations.
Strengths and limitations
Strengths of our review include use of a pre-specified
protocol, a systematic and comprehensive search strat-
egy tailored to each bibliographic database, inclusion
only of population-based studies of prevalence using an
objective diagnosis of chlamydia infection, duplicate eli-
gibility screening and data entry, and the lack of exclu-
sions based on language or publication date. It was also
possible to explore sources of heterogeneity using meta-
analysis and meta-regression.
A challenge experienced in our review was the strong
evidence for heterogeneity between studies even after
stratifying by gender, age, and geographic region, which
lead us to conclude that pooled estimates of prevalence
would not be valid. Potential sources of heterogeneity
between studies included study design, measurement
of socioeconomic position, categorisation of reference
groups and analysis of confounding. Differences in age
groups and other variables between studies also lim-
ited the comparability of observations and prevented
inclusion of socioeconomic position in meta-regression
analyses. Ethnicity and level of urbanisation are other
factors that may contribute to variation in prevalence
between populations [4, 28], but were beyond the scope
of the review.
The reliability of prevalence estimates in our review
is limited by the risk of bias in the studies included.
Overall, 95 % of the studies were assessed to be high or
medium risk of important bias, particularly selection bias,
in their estimates. Unfortunately, most studies included in
this review had a lack of data on non-responders, which
meant that it was not possible to adjust estimates for
non-response using multiple imputation, inverse probabil-
ity weighting or other statistical approaches to missing
data [32].
Meta-regression suggested an explanation for only a
small proportion of the between study variation in
prevalence estimates observed in this review. In addition
this approach involves the implicit assumption that true
prevalence is the same in different populations. In this
context, meta-regression mainly serves to identify hy-
potheses to be explored in future studies [49, 50]. Fur-
ther, the measures of possible sources of between study
variation used in meta-regression analyses in this review
were relatively crude and likely to themselves be subject
to measurement error. For example, response rates are
only a proxy for the potential for selection bias, and
whether or not data collection occurred before/after
2006 will only crudely index an influence of the intro-
duction of Chlamydia control programmes. There were
too few studies to robustly examine the influence of
country where the study was carried out on variation in
prevalence.
There were also limitations related to analysis of socio-
economic position in this review. Reporting bias may
have led to overestimation of associations. At least one
study [26] did not report the results of analyses where
no association was found. Other potential sources of
bias could have worked in either direction, for example
potential residual confounding and adjustment of socio-
economic position for variables that may be on the
causal pathway between exposure and outcome or con-
sequences of the outcome (such as early sexual debut,
number of sexual partners and symptoms of infection).
Five out of thirteen observations included in the meta-
analysis of educational measures were not adjusted for
potential confounders, because no positive association
was found in unadjusted analyses. In one study, the as-
sociation between parental socioeconomic disadvantage
and chlamydia was substantially attenuated and reversed
in direction after adjusting for drug taking, contraceptive
use and exposure to passive smoke [38]. In accordance
with the study protocol, adjusted estimates were used in
this review; however, both adjusted and unadjusted esti-
mates may be subject to bias.
Some health services data and studies from some set-
tings suggest that there are inequities in the burden of
chlamydia infections between ethnic groups, with higher
rates in some black ethnic groups than other black and
non-black ethnic groups [4, 8, 46, 51–53]. UK population-
based surveys have been inconclusive in this regard, which
may reflect issues related to sample size or other meth-
odological challenges [37, 51]. Chlamydia prevalence has
also been found to vary by geographic location, including
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between countries, and according to urban/rural residence
in some studies [28, 54] and between regions and cities in
the same country in others [43, 46]. Detailed consideration
of these questions is beyond the scope of this paper. Our
focus on variations in prevalence by age, gender and so-
cioeconomic position in part reflected the potential im-
portance of these demographic factors for the design of
control interventions, and was because extant evidence of
their association with chlamydia infection appeared incon-
clusive [10, 55].
Research and policy implications
The present systematic review builds on two recent re-
views [10, 55] by including more recent studies and by
using meta-analysis and meta-regression to pool results
and explore heterogeneity. One of these previous reviews
examined inequities in prevalence by socioeconomic
position and found inconclusive evidence of an associ-
ation between chlamydia infection and socioeconomic
position, concluding that a relationship cannot be as-
sumed [10]. The present review provides new evidence
that young people-specific and area-based measures of
socioeconomic position are associated with chlamydia
prevalence when pooled across studies, and finds similar
inconclusive results for parental or household measures.
The second review examined risk difference in preva-
lence between the sexes for individual studies and found
that any difference in prevalence between women and
men is likely to be modest [55]. Our systematic review
found weak evidence of differences in chlamydia preva-
lence by gender and age (under and over 20 years).
These findings were from meta-regression and are best
interpreted as hypotheses for testing in future research.
There are several possible mechanisms for socioeco-
nomic inequities in chlamydia infections. These include
lower engagement with Chlamydia control activities
amongst disadvantaged individuals. Young people from
families with lower socio-economic position may also be
at greater risk of having a chlamydia infection, because
individual, family, interpersonal, community and struc-
tural factors reduce the perceived benefits of safe sex, re-
duce consistency of condom use, reduce sexual health
service provision and use, and increase other risk factors
for unsafe sex, such as substance use, and mental health
problems [10, 56–58]. Potential reasons for gender dif-
ferences in risk for chlamydia include age differences in
sexual partnerships [59], biological differences, cervical
ectopy and use of hormonal contraceptives in women,
and circumcision in men [55]. However, apparent differ-
ences by gender may in part be due to selection bias,
which may operate in a different way in each sex [55].
Our review points to the need to monitor and address
social variation in the risk of infection, in order to avoid
the potential for screening programmes to exacerbate
inequalities [9]. In the early years of England’s National
Chlamydia Screening Programme, screening provision,
coverage and positivity were all higher in socio-
economically deprived areas than more affluent areas
[13, 60]. However, recent population-based evidence
on reported tests in the past year suggest that screen-
ing uptake is similar across all levels of neighbourhood
deprivation [37]. Our findings indicate the need for
greater uptake of screening in disadvantaged areas to
adequately address increased risk of infection. Another
potential challenge for screening programmes is en-
suring sufficient uptake of tests among people aged 20
to 24 years. This age group is more difficult to reach
than younger age groups who are more likely to be in
full-time education. Other studies suggest that chlamydia
screening uptake may be lower in men and in older age
groups [13, 37]. More may need to be done to meet the
need for screening in older men.
Conclusion
This review found strong evidence of an association be-
tween chlamydia infection and measures of socioeconomic
disadvantage, including respondent’s educational attain-
ment, employment and area-based deprivation. Prevalence
of chlamydia varied within the UK and across similar
countries, even after stratifying by age, gender and region.
There was weaker evidence that risk of infection varies by
gender and age. However, there remains uncertainty about
the role of study characteristics such as risk of bias and
study focus (general or sexual health) in driving variation
in prevalence estimates. Studies with higher response
rates, larger sample sizes and analysis of data on non-
responders may help to shed light on existing evidence
gaps. Population-based serological studies examining
the prevalence of chlamydia antibodies may also help
to improve the evidence on the extent and distribution
of infections [61].
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